
RAI- REFRACTORY PAPILLARY THYROID CARCINOMA: ONE OF THE FIRST PATIENTS TO USE LENVATINIB IN THE COUNTRY, CASE REPORT
Author(s) -
Júlia Pastorello,
Emanuela Lando,
Marina Ractz Bueno,
Camila dos Santos do Amaral,
Cristiane Pagnussat Cechetti
Publication year - 2022
Publication title -
international journal of health science
Language(s) - English
Resource type - Journals
ISSN - 2764-0159
DOI - 10.22533/at.ed.1592172221037
Subject(s) - lenvatinib , refractory (planetary science) , medicine , thyroid carcinoma , papillary carcinoma , oncology , thyroid , thyroid cancer , biology , astrobiology